InnovaRx Innova Health Strategies

D65

Disseminated intravascular coagulation [defibrination syndrome]

Billable FY2026 2025-10-01 → 2026-09-30
Exclusions 13 never code together
D65code
Excludes1
D50-D89chapter
Excludes2
  • autoimmune disease (systemic) NOS (M35.9)M35.9
  • certain conditions originating in the perinatal period (P00-P96)P00-P96
  • complications of pregnancy, childbirth and the puerperium (O00-O9A)O00-O9A
  • congenital malformations, deformations and chromosomal abnormalities (Q00-Q99)Q00-Q99
  • endocrine, nutritional and metabolic diseases (E00-E88)E00-E88
  • human immunodeficiency virus [HIV] disease (B20)B20
  • injury, poisoning and certain other consequences of external causes (S00-T88)S00-T88
  • neoplasms (C00-D49)C00-D49
  • symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified (R00-R94)R00-R94

Excludes1 — never code together. The excluded condition and this one are mutually exclusive.

Excludes2 — not included here, but the patient may have both. Code both when documented.

Instructional notes 8
D65code
Inclusion terms
  • Afibrinogenemia, acquired
  • Consumption coagulopathy
  • COVID-19 associated diffuse or disseminated intravascular coagulopathy
  • Diffuse or disseminated intravascular coagulation [DIC]
  • Fibrinolytic hemorrhage, acquired
  • Fibrinolytic purpura
  • Purpura fulminans
Code also
  • , if applicable, associated condition
Index entries leading here 14
  • Absence (of) (organ or part) (complete or partial)
    • fibrinogen (congenital) D68.2
  • Afibrinogenemia D68.8
  • Fibrinogenopenia D68.8
  • Hypofibrinogenemia D68.8
  • Deficiency, deficient
    • fibrinogen (congenital) (hereditary) D68.2
  • Coagulation, intravascular (diffuse) (disseminated) — see also Defibrination syndrome
    • COVID-19 associated D65
  • Coagulopathy — see also Defect, coagulation
    • consumption D65
    • intravascular D65
  • Glomerulonephritis N05.9
    • in (due to)
      • defibrination syndrome D65
      • disseminated intravascular coagulation D65
  • Defibrination (syndrome) D65
  • Syndrome — see also Disease
    • DIC (diffuse or disseminated intravascular coagulopathy) D65
    • ICF (intravascular coagulation-fibrinolysis) D65
    • intravascular coagulation-fibrinolysis (ICF) D65
    • IVC (intravascular coagulopathy) D65
  • Disorder (of) — see also Disease
    • glomerular (in) N05.9
      • disseminated intravascular coagulation D65
  • Fibrinolysis (hemorrhagic) (acquired) D65
  • Purpura D69.2
    • fulminans, fulminous D65
    • gangrenous D65
  • Proteolysis, pathologic D65
Medications 1

MED-RT files conditions by MeSH, which carves the world differently from ICD-10. These are name matches on this code's description, offered as candidates — not as an assertion that they are this code.

Additional references
AHA Coding Clinic® Licence required

Official coding advice for this code. Published by the American Hospital Association. Not included in this installation.

Risk adjustment

CMS22HCC48 ESRD21HCC48 ESRD24HCC48

Presence is a property of the code. Untick a model to hide it everywhere.

This code

Billable
yes
Code set
FY2026
Block
D65-D69

Present FY2024–FY2027.